ArticleExperimental and therapeutic medicine2023

Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective study.

Zhiheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.